We are pleased to be a part of the 3rd Annual Ophthalmic Drugs Conference and Focus Day, taking place on the 18th-20th November 2019 in London, UK.
Expert presentations, the three-day agenda, with brand-new initiative - Focus Day on ‘Novel Drug Delivery Through a Complex Barrier’ definitely offer new insights on the future for ocular drug development and many opportunities for peer-to-peer networking.
Novel model for corneal permeability in vitro testing through the combined use of collagen-based hydrogels with stratified corneal epithelial cells
A synthetic metalloporphyrin SOD mimetic protects corneal epithelial cells from oxidative stress-induced damage in vitro and in vivo
Subscribe to Our Newsletter!
We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!